Connect your AI

Abbott ABT Business Combination, Contingent Consideration, Liability

Business Combination, Contingent Consideration, Liability at other companies

Boston ScientificBSX

——

Medline, Inc. MDLN

——

AmgenAMGN

——

West Pharmaceutical ServicesWST

——

Other financials

Income statement

Revenue$11.2B+7.8%

Gross profit$6.3B+6.5%

Operating income$1.3B-20.6%

Net income$1.1B-18.7%

EPS (diluted)$0.61-19.7%

Balance sheet

Cash & equivalents$6.8B+4.2%

Total debt$34.0B+157%

Total equity$52.1B+6.7%

Total assets$110.43B+35.6%

Cash flow

Operating cash flow$1.3B-7.2%

CapEx$399.0M-17.6%

Free cash flow$916.0M-1.8%

Valuation

Market cap$154.15B-22.5%

Enterprise value$181.39B-13.1%

P/E24.6×+9.8×

P/S3.4×-1.3×

Profitability

Gross margin56.3%+0.4pp

Operating margin17.1%+0.2pp

Net margin13.9%-18.0pp

Returns & leverage

Return on equity12.4%-18.4pp

Debt / equity0.7×+0.4×

Current ratio1.4×-0.4×

Where this comes from

Reported directly by Abbott in its filing.

Tagged under the XBRL concept us-gaap:BusinessCombinationContingentConsiderationLiability.

The official record: Abbott’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Abbott's business combination, contingent consideration, liability.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Abbott's business combination, contingent consideration, liability?: Abbott (ABT) reported business combination, contingent consideration, liability of $304M in Q1 2026.